Case Background:
This is a federal securities fraud class action lawsuit on behalf of those who purchased or otherwise acquired Walgreens Boots Alliance, Inc. (“WBA”) (NASDAQ: WBA) common stock between October 14, 2021 and June 26, 2024, inclusive (the “Class Period”).
WBA is one of the largest retail pharmacy chains in the world, and in recent years announced that it would invest in a partnership with VillageMD, which is a startup primary care provider, with the intent of opening full service primary care clinics in roughly 1,000 of WBA’s 9,000 U.S. stores.
The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material facts about the company’s business, operations, and prospects. Specifically, Defendants misrepresented and/or failed to disclose that: (1) despite touting new clinic openings, the existing clinics faced chronic understaffing, resulting in many sitting empty for months; (2) the lack of physicians on staff subsequently resulted in the clinics having virtually no patients; (3) upon seeing the failed clinics, WBA secretly shut down the VillageMD rollout in 2022, while continuing to tout its purported success; and (4) as a result of the foregoing, Defendants’ statements about the company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.
Current Status of Case:
On January 5, 2026, the Court granted in part and denied in part Defendants’ Motion to Dismiss the Amended Complaint. This action is ongoing.
If you wish to discuss this action or have any questions, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.